300142

Walvax Biotechnology
300142

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥20.52B
EV
CN¥19.54B
Shares Outstanding
1.60B
Beta
0.36

Wall Street View

Analyst Rating
SELL
Analyst Target Price
CN¥8.00
P/E 2025E
58.32x
P/Revenue 2025E
7.75x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Walvax Biotechnology Co., Ltd.

gainify
300142

Walvax Biotechnology Co., Ltd.

300142

Walvax Biotechnology Co., Ltd., researches, develops, produces, and markets vaccines in China. The company offers SARS-CoV-2 mRNA vaccine, an immunization to prevent COVID-19 to individuals 18 years of age and older; 13-valent pneumococcal polysaccharide conjugate vac...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Yao, Wei

Employees

2,388

IPO Date

2010-11-12

Headquarters

No. 395 Kexin Road, Wuhua District, Kunming, Yunnan Province, 650101, China

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.